# Moderna Shares Jump After Citigroup Downgrade

> Moderna stock surges 6.7% as Citigroup lifts price target to $80.
- Title: Moderna Shares Jump After Citigroup Downgrade | Shortify
- Summary: Moderna stock surges 6.7% as Citigroup lifts price target to $80. Moderna shares rose 6.7% to $202.70 after Citigroup raised its price target by 33.3% to…
- Keywords: moderna, citigroup, price target, sell rating, stock market, merger and acquisition, Shares, Jump, Downgrade, Alphastreet - Earnings Decoded. Market Intelligence Delivered
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/moderna-jumps-6-7-after-citigroup-downgrades-to-sell
- Author: AlphaStreet Newsdesk
- Published: 2026-10-05T17:32:03+00:00
- Read time: 1 min
- Topics: moderna, citigroup, price target, sell rating, stock market, merger and acquisition
## Moderna Shares Jump
Moderna shares jumped 6.7% Monday to close at $202.70 after Citigroup raised its price target by 33.3%.
## Price Target Revised
The Citigroup revision moved the firm’s target from $60 to $80, though analysts maintained their Sell rating.
## Heavy Trading Volume
The biotech company saw 10.8M shares change hands as investors responded to the analyst action.
## Market Capitalization Boost
The day’s move added substantial value to Moderna’s $80.9B market capitalization.
## M&A Signals
Investors are now focused on whether momentum can sustain itself and what catalysts might emerge from rumored strategic activity.
## Key takeaway

Moderna shares rose 6.7% to $202.70 after Citigroup raised its price target by 33.3% to $80, maintaining a Sell rating.